Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HealthyCell is a private U.S. consumer health and nutraceutical company that develops and sells gel-based dietary supplements under its proprietary MicroGel delivery platform. The company markets direct-to-consumer products focused on daily nutrition, sleep, cognition, immune support, heart health, joint mobility, bone health, glucose support, eye health, beauty, and healthy aging. HealthyCell positions its products around improved nutrient absorption versus traditional pills and powders, and states that its formulas are developed with clinically effective doses and manufactured in U.S. FDA-inspected, GMP-compliant facilities. The business appears to be commercial-stage rather than a drug-development biotech, with revenue derived from branded supplement sales rather than a therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HealthyCell.